Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[350 Pages Report] Newly released data from nucleotides market analysis shows that global demand of overall nucleotides market enjoyed year-on-year growth of 5.8% in 2021 to total US$ 559.9 Mn and it is expected to grow with a CAGR of 6.1% over the forecasted period.
In the past few years, the consumer base around the globe is becoming aware of the usage of premixes in infant nutrition applications. Thus consumers started opting for infant nutrition products containing premixes which are expected to trigger growth to the nucleotides market.
In addition to this, the disposable income of the consumer base around the globe is increasing and, as a result, their propensity to spend on food products with improved health benefits is also increasing. Thus the consumer base around the globe started opting for food products with health beneficial ingredients such as nucleotides.
Sales of nucleotides will represent 5.8% of the overall demand in the global customized premix market. The increasing demand for food premixes owing to health benefits associated with it is propelling growth to the overall customized premix market. Moreover, growing awareness among the pet owners regarding the diet of their pet is increasing demand for feed premixes which is expected to propel growth to the nucleotides market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Market Statistics | Details |
---|---|
H1,2021 (A) | 5.7% |
H1,2022 Projected (P) | 5.8% |
H1,2022 Outlook (O) | 6.4% |
BPS Change : H1,2022 (O) - H1,2022 (P) | (+) 58 ↑ |
BPS Change : H1,2022 (O) - H1,2021 (A) | (+) 63.8 ↑ |
FMI provides a half-yearly comparison study and evaluation of the worldwide market's growth rates as well as its future development potential. Under the subjective effect of macro and industry variables, certain demographic and innovation aspects dominate the market.
Some new developments that have taken place in these markets include:
The global market for nucleotides is expected to rise by 5.7 percent in the first half of 2021. But not all regions have experienced this increase equally, with developing markets experiencing greater growth rates of 6.4 percent (H1 2022 Expected). The difference between predicted and projected growth for H1 2022 is hence 63.8 BPS points.
The primary causes of this variation in growth rate are ascribed to the market's slow or rapid uptake during the first half of the projected period as a result of improving end user demand in important economies and their expanding populations. Particularly, the consumption patterns of the USA and China are both increasing, which is driving up demand for nucleotides.
5.8% of the total global demand for customised premix will be met by sales of nucleotides. The market for customised premixes as a whole is expanding due to the rising demand for food premixes and their associated health benefits. Additionally, the demand for feed premixes is rising as pet owners become more aware of what their pets should eat, which is anticipated to drive expansion in the nucleotides market.
In the second half of the projection period, numerous other market segments are anticipated to perform reasonably and achieve attractive development possibilities.
Despite these promising developments, the business is still expected to face significant obstacles, such as shifting customer tastes, strict trade restrictions, and a lack of security in the supply of raw materials and other production inputs.
The global nucleotides market is expected to value at US$ 559.9 Mn in 2021. However, it is projected to reach US$ 1,010.5 Mn by the end of 2031 growing with a CAGR of 6.1%.
The global nucleotide market is now seeing rapid expansion. To a certain extent, growth is due to increased demand from a variety of end consumers. Nucleotides, for example, have seen a significant surge in use in animal feed additives, the food and beverage sector, pharmaceuticals, and research and diagnostics. The market is expected to see a significant increase in demand in the coming years. As customers become more aware of the adverse consequences of savoury additives, sales of nucleotide-based flavour enhancers are expected to rise in the coming years.
Furthermore, the market's growth prospects will be boosted by the expanding spectrum of use in the pharmaceuticals sector, particularly in Canada and the United States, as well as continually rising demand from the cattle industry.
According to FMI, the US is dominating the North American region with a market share of 91.2% valued at US$ 175.6 Mn in the year 2021 and it is expected to reach US$ 286.7 Mn by the year 2031 growing at a CAGR of 5.6% over the forecasted period.
The presence of key players in the US is one of the major growth enablers to the US nucleotides market. These key players are focusing on changing consumer demand and hence introducing the products according to the need of the consumers. For instance, some manufacturers have introduced gluten-free nucleotide premix to the market. As the huge consumer base in the US are demanding gluten-free food products the demand for gluten-free ingredients such as nucleotides which are used in food products is also gaining traction.
The German nucleotides market size in 2021 is estimated to account for a value of US$ 33.6 Mn and it is expected to grow with a CAGR of 5.5% over the forecasted period reaching US$ 54.2 Mn.
The key reason behind the dominance of Germany in the European nucleotides market is the growing demand for nucleotides in infant nutrition. From the past few years, the consumer base in Germany has become aware of the positive impact of nucleotides enriched baby food on infant nutrition. Thus the demand for nucleotides enriched baby food is souring growth to the German nucleotides market.
Animals' nucleotides are digested in the gut, which has an impact on the proliferation of beneficial gut bacteria. ATP breakdown begins immediately after an animal dies due to respiratory arrest, resulting in the synthesis of catabolite nucleotides such as inosine (Ino), inosine monophosphate (IMP), and, later, hypoxanthine (Hx). Measuring nucleotide levels in tissues provides an objective indicator of the freshness of fish and meat, such as beef, pork, lamb, poultry, and sub-products.
Thus due to increasing incidents of animal diseases, the consumer base in the UK have become aware of maintaining adequate metabolism rates in livestock which is propelling growth to the UK nucleotides market.
India is dominating the South Asia nucleotides market holding a 40.6% share valued at US$ 2,242.2 Mn in the year 2021 and it is expected to grow with a CAGR of 9.7% reaching a market value of US$ 5,142.4 Mn by the year 2031.
Being one of the prominent developing countries the disposable income of the consumer base in India is continuously increasing. Thus with increasing disposable income consumers’ willingness to spend on nutritional food products is also increasing. Thus food product manufacturers are using ingredients such as nucleotides which help in increasing the nutritional value of the product. Hence the growing demand for nutritional food products is promoting sales of nucleotides in India.
For the past few years, China is experiencing significant growth in the demand for flavour enhancers. As the nucleotides boost sensory acceptability through taste and flavour, increase the richness, impact, continuity, and harmony of food flavours. Moreover, it also enhances the performance of smells, and provide for cost savings in formulations. Owing to which the sales of nucleotides are expected to gain traction in China and it is expected to grow with a significant CAGR of 8.9% over the forecasted period.
According to FMI, the Diagnostic research segment is holding a market share of 62.0% valued at US$ 346.9 Mn in the year 2021 and it is expected to reach US$ 617.5 Mn by 2031 growing at a CAGR of 6.6%. From the past few years, the demand for quick and accurate diagnosis of numerous genetic diseases is increasing.
Thus with the growing demand for quick and accurate diagnosis, the demand for nucleotides is also increasing as it is one of the best alternatives available in the market for diagnostic research.
According to FMI, TaqMan Allelic Discrimination technology is estimated to dominate the technology segment holding a 45.8% share in the global market valued at US$ 256.6 Mn in the year 2021 and it is expected to grow with 6.8% CAGR in the forecasted period.
TaqMan allelic discrimination, which has been widely used to define single nucleotide polymorphisms, is one of the most effective approaches to evaluate genotypes.
However, there are numerous disorders caused by massive deletions that can only be detected by copy number analysis, multiplex ligation-dependent probe amplification, or direct sequencing, all of which are time-consuming, expensive, and difficult to interpret and utilize in high-throughput research. Thus as an alternative approach, TaqMan allelic discrimination technology is used.
According to market research analysis Ohly GmbHNanjing Bio Together Co., Ltd., ThermoFisher Scientific Inc., Agilent Technologies Inc., DSM Nutritional Products Ltd., Lallemand Inc., Affymetrix Inc., PR omega Corporation, Biorigin, Meihua Group, Star Lake Bioscience Co., NuEra Nutrition, F. Hoffmann-La Roche Ltd., CJ CheilJedang Corporation and many other.
Companies today operate in a fast-paced business climate, guided by shifting consumer desires. To be relevant in the market, it is critical that they keep track of changing consumer tastes and preferences. Companies are focusing on the launch of products with unique qualities, driven by the increased demand for nutritional premixes.
Attribute | Details |
---|---|
Market Size Value in 2020 | US$ 529.2 Million |
Market Forecast Value in 2031 | US$ 1,010.5 Million |
Global Growth Rate | 6.1 |
Forecast Period | 2021 to 2031 |
Historical Data Available for | 2016 to 2020 |
Market Analysis | MT for Volume and US$ Mn for Value |
Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA |
Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
Key Market Segments Covered | Technology, Application and Regions |
Key Companies Profiled |
|
Pricing | Available upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By Technology:
By Application:
By Region:
Currently nucleotides market is worth more than US$ 529.2 Mn.
Nucleotides consumption is expected to grow at a CAGR of around 6.1% during the period 2021-2031.
In terms of revenue, nucleotides grew at a CAGR of around 4.9% during 2016-2020
Rising demand for better nutritive qualities in flavour enhancers is the latest trend of nucleotides being observed in the market.
Market players are opting for technological advancement, new product developments and production capacity expansion.
The top 5 producers of nucleotides hold around 20-30% of the market share.
The US, China Germany, and China are the major countries driving demand for nucleotides.
East Asia holds around 12.8% of the total nucleotides revenue share.
US nucleotides market is projected to grow at a CAGR of around 5.6% over the next ten years.
The report presents a detailed cost analysis of nucleotides based on nature i.e. organic and conventional.
A nucleotide is an organic molecule that is the building block of DNA and RNA.
Nucleotides are in particular essential for replication of DNA and transcription of RNA in rapidly dividing stages.
1. Market Overview 1.1. Market Coverage / Taxonomy 1.2. Market Definition / Scope / Limitations 2. The Massive Impact of the Crisis 2.1. Global Market Forecast Scenario Comparison of Annual Growth Rates for short Term (2021-2025) and Long Term (2026-2031) 2.1.1. Optimistic Scenario 2.1.2. Likely Scenario 2.1.3. Pessimistic Scenario 2.2. Key Factors Impacting the Market Note: Market Assessment shall be Provided for Likely Scenario 3. Market Dynamics 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends By Region 3.5. Product Launches 3.6. Product Claims & Nutritional Information Scan by Buyers 3.7. Macro-Economic Factors 3.8. Forecast Factors - Relevance & Impact 3.9. Consumers Survey Analysis 4. Key Regulations 4.1. Packaging & Labelling Regulations 4.2. Certifications and Certifying Agency Overview 4.3. Import/Export Policies 5. Value Chain Analysis 5.1. Operating margins at each node of supply chain 5.2. List of Active Market Participants 5.2.1. Raw Material Suppliers 5.2.2. Product Manufacturers 5.2.3. Key Brands 6. Global Market Demand Analysis 2016-2020 and Forecast, 2021-2031 6.1. Historical Market Volume (Metric Tons) Analysis, 2016-2020 6.2. Current and Future Market Volume (Metric Tons) Projections, 2021-2031 6.3. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis (US$/Metric Tons) By Prominent Regions 7.2. Pricing Break-up By category 7.3. Global Average Pricing Analysis Benchmark 8. Global Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031 8.1. Historical Market Value (US$ Mn) Analysis, 2016-2020 8.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Technology 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Technology, 2016 - 2020 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Technology, 2021-2031 9.3.1. TaqMan allelic discrimination 9.3.2. Gene chips & microarrays 9.3.3. SNP by pyrosequencing 9.3.4. Others 9.4. Market Attractiveness Analysis By Technology 10. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2016 - 2020 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2021-2031 10.3.1. Pharmaceuticals 10.3.2. Diagnostics research 10.3.3. Food & beverage additive 10.3.4. Animal feed additive 10.3.5. Others 10.4. Market Attractiveness Analysis By Application 11. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2016 - 2020 11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2021-2031 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2016-2020 and Forecast 2021-2031 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 12.4.1. By Country 12.4.1.1. U.S. 12.4.1.2. Canada 12.4.2. By Technology 12.4.3. By Application 12.5. Market Attractiveness Analysis 12.5.1. By Technology 12.5.2. By Application 12.6. Market Trends 12.7. Key Market Participants - Intensity Mapping 12.8. Drivers and Restraints - Impact Analysis 13. Latin America Market Analysis 2016-2020 and Forecast 2021-2031 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 13.4.1. By Country 13.4.2. Brazil 13.4.3. Mexico 13.4.4. Rest of Latin America 13.4.5. By Technology 13.4.6. By Application 13.5. Market Attractiveness Analysis 13.5.1. By Technology 13.5.2. By Application 13.6. Market Attractiveness Analysis 13.7. Market Trends 13.8. Key Market Participants - Intensity Mapping 13.9. Drivers and Restraints - Impact Analysis 14. Europe Market Analysis 2016-2020 and Forecast 2021-2031 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 14.4.1. By Country 14.4.2. Germany 14.4.3. Italy 14.4.4. France 14.4.5. U.K. 14.4.6. Spain 14.4.7. BENELUX 14.4.8. Russia 14.4.9. Rest of Europe 14.4.10. By Technology 14.4.11. By Application 14.5. Market Attractiveness Analysis 14.5.1. By Technology 14.5.2. By Application 14.6. Market Attractiveness Analysis 14.7. Market Trends 14.8. Key Market Participants - Intensity Mapping 14.9. Drivers and Restraints - Impact Analysis 15. East Asia Market Analysis 2016-2020 and Forecast 2021-2031 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 15.4.1. By Country 15.4.2. China 15.4.3. Japan 15.4.4. South Korea 15.4.5. By Technology 15.4.6. By Application 15.5. Market Attractiveness Analysis 15.5.1. By Technology 15.5.2. By Application 15.6. Market Attractiveness Analysis 15.7. Market Trends 15.8. Key Market Participants - Intensity Mapping 15.9. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2016-2020 and Forecast 2021-2031 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 16.4.1. By Country 16.4.2. India 16.4.3. Thailand 16.4.4. Indonesia 16.4.5. Malaysia 16.4.6. Singapore 16.4.7. Rest of South Asia 16.4.8. By Technology 16.4.9. By Application 16.5. Market Attractiveness Analysis 16.5.1. By Technology 16.5.2. By Application 16.6. Market Attractiveness Analysis 16.7. Market Trends 16.8. Key Market Participants - Intensity Mapping 16.9. Drivers and Restraints - Impact Analysis 17. Oceania Market Analysis 2016-2020 and Forecast 2021-2031 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 17.4.1. By Country 17.4.2. Australia 17.4.3. New Zealand 17.4.4. By Technology 17.4.5. By Application 17.5. Market Attractiveness Analysis 17.5.1. By Technology 17.5.2. By Application 17.6. Market Attractiveness Analysis 17.7. Market Trends 17.8. Key Market Participants - Intensity Mapping 17.9. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2031 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 18.4.1. By Country 18.4.1.1. GCC Countries 18.4.1.2. North Africa 18.4.1.3. South Africa 18.4.1.4. Rest of Middle East and Africa 18.4.2. By Technology 18.4.3. By Application 18.5. Market Attractiveness Analysis 18.5.1. By Technology 18.5.2. By Application 18.6. Market Attractiveness Analysis 18.7. Market Trends 18.8. Key Market Participants - Intensity Mapping 18.9. Drivers and Restraints - Impact Analysis 19. Key Countries Nucleotides Market Analysis 2016–2020 and Forecast 2021–2031 19.1. U.S. 19.1.1. Introduction 19.1.2. Pricing Analysis (2016, 2021, 2031) 19.1.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.1.3.1. By Technology 19.1.3.2. By Application 19.2. Canada 19.2.1. Pricing Analysis (2016, 2021, 2031) 19.2.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.2.2.1. By Technology 19.2.2.2. By Application 19.3. Brazil 19.3.1. Pricing Analysis (2016, 2021, 2031) 19.3.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.3.2.1. By Technology 19.3.2.2. By Application 19.4. Mexico 19.4.1. Pricing Analysis (2016, 2021, 2031) 19.4.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.4.2.1. By Technology 19.4.2.2. By Application 19.5. Argentina 19.5.1. Pricing Analysis (2016, 2021, 2031) 19.5.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.5.2.1. By Technology 19.5.2.2. By Application 19.6. Chile 19.6.1. Pricing Analysis (2016, 2021, 2031) 19.6.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.6.2.1. By Technology 19.6.2.2. By Application 19.7. Germany 19.7.1. Pricing Analysis (2016, 2021, 2031) 19.7.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.7.2.1. By Technology 19.7.2.2. By Application 19.8. Italy 19.8.1. Pricing Analysis (2016, 2021, 2031) 19.8.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.8.2.1. By Technology 19.8.2.2. By Application 19.9. France 19.9.1. Pricing Analysis (2016, 2021, 2031) 19.9.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.9.2.1. By Technology 19.9.2.2. By Application 19.10. U.K. 19.10.1. Pricing Analysis (2016, 2021, 2031) 19.10.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.10.2.1. By Technology 19.10.2.2. By Application 19.11. Spain 19.11.1. Pricing Analysis (2016, 2021, 2031) 19.11.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.11.2.1. By Technology 19.11.2.2. By Application 19.12. Benelux 19.12.1. Pricing Analysis (2016, 2021, 2031) 19.12.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.12.2.1. By Technology 19.12.2.2. By Application 19.13. Russia 19.13.1. Pricing Analysis (2016, 2021, 2031) 19.13.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.13.2.1. By Technology 19.13.2.2. By Application 19.14. India 19.14.1. Pricing Analysis (2016, 2021, 2031) 19.14.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.14.2.1. By Technology 19.14.2.2. By Application 19.15. Thailand 19.15.1. Pricing Analysis (2016, 2021, 2031) 19.15.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.15.2.1. By Technology 19.15.2.2. By Application 19.16. Indonesia 19.16.1. Pricing Analysis (2016, 2021, 2031) 19.16.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.16.2.1. By Technology 19.16.2.2. By Application 19.17. Malaysia 19.17.1. Pricing Analysis (2016, 2021, 2031) 19.17.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.17.2.1. By Technology 19.17.2.2. By Application 19.18. China 19.18.1. Pricing Analysis (2016, 2021, 2031) 19.18.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.18.2.1. By Technology 19.18.2.2. By Application 19.19. Japan 19.19.1. Pricing Analysis (2016, 2021, 2031) 19.19.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.19.2.1. By Technology 19.19.2.2. By Application 19.20. South Korea 19.20.1. Pricing Analysis (2016, 2021, 2031) 19.20.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.20.2.1. By Technology 19.20.2.2. By Application 19.21. Australia 19.21.1. Pricing Analysis (2016, 2021, 2031) 19.21.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.21.2.1. By Technology 19.21.2.2. By Application 19.22. New Zealand 19.22.1. Pricing Analysis (2016, 2021, 2031) 19.22.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.22.2.1. By Technology 19.22.2.2. By Application 19.23. GCC Countries 19.23.1. Pricing Analysis (2016, 2021, 2031) 19.23.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.23.2.1. By Technology 19.23.2.2. By Application 19.24. Central Africa 19.24.1. Pricing Analysis (2016, 2021, 2031) 19.24.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.24.2.1. By Technology 19.24.2.2. By Application 19.25. Northern Africa 19.25.1. Pricing Analysis (2016, 2021, 2031) 19.25.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.25.2.1. By Technology 19.25.2.2. By Application 19.26. South Africa 19.26.1. Pricing Analysis (2016, 2021, 2031) 19.26.2. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 19.26.2.1. By Technology 19.26.2.2. By Application 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Company Share Analysis of Top Players 20.3. Market Presence Analysis 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Deep Dive (Tentative List) 21.2.1. Ohly GmbH 21.2.1.1. Overview 21.2.1.2. Product Portfolio 21.2.1.3. Profitability by Market Segments (Product/Channel/Region) 21.2.1.4. Sales Footprint 21.2.1.5. Strategy Overview 21.2.1.5.1. Marketing Strategy 21.2.1.5.2. Product Strategy 21.2.2. Nanjing Bio Together Co., Ltd. 21.2.2.1. Overview 21.2.2.2. Product Portfolio 21.2.2.3. Profitability by Market Segments (Product/Channel/Region) 21.2.2.4. Sales Footprint 21.2.2.5. Strategy Overview 21.2.2.5.1. Marketing Strategy 21.2.2.5.2. Product Strategy 21.2.3. Agilent Technologies Inc. 21.2.3.1. Overview 21.2.3.2. Product Portfolio 21.2.3.3. Profitability by Market Segments (Product/Channel/Region) 21.2.3.4. Sales Footprint 21.2.3.5. Strategy Overview 21.2.3.5.1. Marketing Strategy 21.2.3.5.2. Product Strategy 21.2.4. PR omega Corporation 21.2.4.1. Overview 21.2.4.2. Product Portfolio 21.2.4.3. Profitability by Market Segments (Product/Channel/Region) 21.2.4.4. Sales Footprint 21.2.4.5. Strategy Overview 21.2.4.5.1. Marketing Strategy 21.2.4.5.2. Product Strategy 21.2.5. Biorigin 21.2.5.1. Overview 21.2.5.2. Product Portfolio 21.2.5.3. Profitability by Market Segments (Product/Channel/Region) 21.2.5.4. Sales Footprint 21.2.5.5. Strategy Overview 21.2.5.5.1. Marketing Strategy 21.2.5.5.2. Product Strategy 21.2.6. Meihua Group 21.2.6.1. Overview 21.2.6.2. Product Portfolio 21.2.6.3. Profitability by Market Segments (Product/Channel/Region) 21.2.6.4. Sales Footprint 21.2.6.5. Strategy Overview 21.2.6.5.1. Marketing Strategy 21.2.6.5.2. Product Strategy 21.2.7. Star Lake Bioscience Co. 21.2.7.1. Overview 21.2.7.2. Product Portfolio 21.2.7.3. Profitability by Market Segments (Product/Channel/Region) 21.2.7.4. Sales Footprint 21.2.7.5. Strategy Overview 21.2.7.5.1. Marketing Strategy 21.2.7.5.2. Product Strategy 21.2.8. NuEra Nutrition 21.2.8.1. Overview 21.2.8.2. Product Portfolio 21.2.8.3. Profitability by Market Segments (Product/Channel/Region) 21.2.8.4. Sales Footprint 21.2.8.5. Strategy Overview 21.2.8.5.1. Marketing Strategy 21.2.8.5.2. Product Strategy 21.2.9. Lallemand Inc. 21.2.9.1. Overview 21.2.9.2. Product Portfolio 21.2.9.3. Profitability by Market Segments (Product/Channel/Region) 21.2.9.4. Sales Footprint 21.2.9.5. Strategy Overview 21.2.9.5.1. Marketing Strategy 21.2.9.5.2. Product Strategy 21.2.10. Affymetrix Inc. 21.2.10.1. Overview 21.2.10.2. Product Portfolio 21.2.10.3. Profitability by Market Segments (Product/Channel/Region) 21.2.10.4. Sales Footprint 21.2.10.5. Strategy Overview 21.2.10.5.1. Marketing Strategy 21.2.10.5.2. Product Strategy 21.2.11. DSM Nutritional Products Ltd. 21.2.11.1. Overview 21.2.11.2. Product Portfolio 21.2.11.3. Profitability by Market Segments (Product/Channel/Region) 21.2.11.4. Sales Footprint 21.2.11.5. Strategy Overview 21.2.11.5.1. Marketing Strategy 21.2.11.5.2. Product Strategy 21.2.12. F. Hoffmann-La Roche Ltd. 21.2.12.1. Overview 21.2.12.2. Product Portfolio 21.2.12.3. Profitability by Market Segments (Product/Channel/Region) 21.2.12.4. Sales Footprint 21.2.12.5. Strategy Overview 21.2.12.5.1. Marketing Strategy 21.2.12.5.2. Product Strategy 21.2.13. ThermoFisher Scientific Inc. 21.2.13.1. Overview 21.2.13.2. Product Portfolio 21.2.13.3. Profitability by Market Segments (Product/Channel/Region) 21.2.13.4. Sales Footprint 21.2.13.5. Strategy Overview 21.2.13.5.1. Marketing Strategy 21.2.13.5.2. Product Strategy 21.2.14. CJ CheilJedang Corporation 21.2.14.1. Overview 21.2.14.2. Product Portfolio 21.2.14.3. Profitability by Market Segments (Product/Channel/Region) 21.2.14.4. Sales Footprint 21.2.14.5. Strategy Overview 21.2.14.5.1. Marketing Strategy 21.2.14.5.2. Product Strategy 21.2.15. Others Prominent Players 21.2.15.1. Overview 21.2.15.2. Product Portfolio 21.2.15.3. Profitability by Market Segments (Product/Channel/Region) 21.2.15.4. Sales Footprint 21.2.15.5. Strategy Overview 21.2.15.5.1. Marketing Strategy 21.2.15.5.2. Product Strategy 22. Assumptions and Acronyms Used 23. Research Methodolog
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Nucleotides Market Value (US$ Mn) and Forecast by Region, 2016–2020 Table 2: Global Nucleotides Market Value (US$ Mn) and Forecast by Region, 2021–2031 Table 3: Global Nucleotides Market Volume (Metric Tons) and Forecast by Region, 2016–2020 Table 4: Global Nucleotides Market Volume (Metric Tons) and Forecast by Region, 2021–2031 Table 5: Global Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020 Table 6: Global Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031 Table 7: Global Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020 Table 8: Global Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031 Table 9: Global Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020 Table 10: Global Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031 Table 11: Global Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020 Table 12: Global Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031 Table 13: North America Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020 Table 14: North America Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031 Table 15: North America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020 Table 16: North America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031 Table 17: North America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020 Table 18: North America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031 Table 19: North America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020 Table 20: North America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031 Table 21: North America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020 Table 22: North America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031 Table 23: North America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020 Table 24: North America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031 Table 25: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020 Table 26: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031 Table 27: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020 Table 28: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031 Table 29: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020 Table 30: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031 Table 31: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020 Table 32: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031 Table 33: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020 Table 34: Latin America Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031 Table 35: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020 Table 36: Latin America Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031 Table 37: Europe Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020 Table 38: Europe Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031 Table 39: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020 Table 40: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031 Table 41: Europe Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020 Table 42: Europe Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031 Table 43: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020 Table 44: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031 Table 45: Europe Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020 Table 46: Europe Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031 Table 47: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020 Table 48: Europe Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031 Table 49: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020 Table 50: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031 Table 51: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020 Table 52: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031 Table 53: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020 Table 54: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031 Table 55: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020 Table 56: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031 Table 57: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020 Table 58: East Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031 Table 59: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020 Table 60: East Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031 Table 61: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020 Table 62: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031 Table 63: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020 Table 64: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031 Table 65: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020 Table 66: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031 Table 67: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020 Table 68: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031 Table 69: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020 Table 70: South Asia Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031 Table 71: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020 Table 72: South Asia Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031 Table 73: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020 Table 74: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031 Table 75: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020 Table 76: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031 Table 77: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020 Table 78: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031 Table 79: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020 Table 80: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031 Table 81: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020 Table 82: Oceania Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031 Table 83: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020 Table 84: Oceania Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031 Table 85: MEA Nucleotides Market Value (US$ Mn) and Forecast by Country 2016–2020 Table 86: MEA Nucleotides Market Value (US$ Mn) and Forecast by Country, 2021–2031 Table 87: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2016–2020 Table 88: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Country, 2021–2031 Table 89: MEA Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2016–2020 Table 90: MEA Nucleotides Market Value (US$ Mn) and Forecast by Technology, 2021–2031 Table 91: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2016–2020 Table 92: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Technology, 2021–2031 Table 93: MEA Nucleotides Market Value (US$ Mn) and Forecast by Application, 2016–2020 Table 94: MEA Nucleotides Market Value (US$ Mn) and Forecast by Application, 2021–2031 Table 95: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2016–2020 Table 96: MEA Nucleotides Market Volume (Metric Tons) and Forecast by Application, 2021–2031
Figure 01: Global Nucleotides Market Value (US$ Mn) and Volume (MT) Forecast, 2021–2031 Figure 02: Global Nucleotides Market Absolute $ Opportunity (US$ Mn), 2021?2031 Figure 03: Global Nucleotides Market Value (US$ Mn) and % Growth by Region, 2021 & 2031 Figure 04: Global Nucleotides Market Y-o-Y Growth Rate by Region, 2021 - 2031 Figure 05: Global Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031 Figure 06: Global Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031 Figure 07: Global Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031 Figure 8: Global Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031 Figure 9: Global Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031 Figure 10: Global Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031 Figure 11: North America Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031 Figure 12: North America Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031 Figure 13: North America Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031 Figure 14: North America Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031 Figure 15: North America Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031 Figure 16: North America Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031 Figure 17: North America Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031 Figure 18: North America Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031 Figure 19: North America Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031 Figure 20: Latin America Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031 Figure 21: Latin America Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031 Figure 22: Latin America Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031 Figure 23: Latin America Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031 Figure 24: Latin America Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031 Figure 25: Latin America Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031 Figure 26: Latin America Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031 Figure 27: Latin America Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031 Figure 28: Latin America Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031 Figure 29: Europe Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031 Figure 30: Europe Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031 Figure 31: Europe Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031 Figure 32: Europe Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031 Figure 33: Europe Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031 Figure 34: Europe Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031 Figure 35: Europe Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031 Figure 36: Europe Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031 Figure 37: Europe Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031 Figure 38: East Asia Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031 Figure 39: East Asia Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031 Figure 40: East Asia Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031 Figure 41: East Asia Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031 Figure 42: East Asia Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031 Figure 43: East Asia Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031 Figure 44: East Asia Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031 Figure 45: East Asia Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031 Figure 46: East Asia Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031 Figure 47: South Asia Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031 Figure 48: South Asia Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031 Figure 49: South Asia Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031 Figure 50: South Asia Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031 Figure 51: South Asia Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031 Figure 52: South Asia Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031 Figure 53: South Asia Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031 Figure 54: South Asia Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031 Figure 55: South Asia Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031 Figure 56: Oceania Nucleotides Market Value (US$ Mn) and % Growth by Country, 2021 & 2031 Figure 57: Oceania Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031 Figure 58: Oceania Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031 Figure 59: Oceania Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031 Figure 60: Oceania Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031 Figure 61: Oceania Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031 Figure 62: Oceania Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031 Figure 63: Oceania Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031 Figure 64: Oceania Nucleotides Market Attractiveness Analysis by Application, 2021 - 2031 Figure 65: Middle East & Africa Nucleotides Market Y-o-Y Growth Rate by Country, 2021 - 2031 Figure 66: Middle East & Africa Nucleotides Market Value (US$ Mn) and % Growth by Technology, 2021 & 2031 Figure 67: Middle East & Africa Nucleotides Market Y-o-Y Growth Rate by Technology, 2021 - 2031 Figure 68: Middle East & Africa Nucleotides Market Value (US$ Mn) and % Growth by Application, 2021 & 2031 Figure 69: Middle East & Africa Nucleotides Market Y-o-Y Growth Rate by Application, 2021 - 2031 Figure 70: Middle East & Africa Nucleotides Market Attractiveness Analysis by Region, 2021 - 2031 Figure 71: Middle East & Africa Nucleotides Market Attractiveness Analysis by Technology, 2021 - 2031 Figure 72: Middle East & Africa Nucleotides Market Attractiveness Analysis by Application, 2021 – 2031
Recommendations
Explore Food and Beverage Insights
View Reports